The Family Smoking Prevention and Tobacco Control Act, signed into law in 2009, gave Food and Drug Administration (FDA) authority to regulate the manufacture, distribution, and marketing of tobacco products. The original intent of this law was to curb youth access to tobacco products and to prevent health effects of addiction to tobacco products, which are two issues that do not apply to premium cigars and pipe tobacco. Youth access to premium cigars is not permitted by IPCPR members and premium cigars are celebratory in nature, with different habitual use patterns than mass market products. By including premium cigars and pipe tobacco in this regulation, FDA ignored the original intent of the Tobacco Control Act, placing nearly 350,000 domestic and international jobs at risk. This page will serve as a resource to help you better understand the new FDA regulations whether you are a retailer, manufacturer, or consumer of premium tobacco products.
IPCPR, CCA AND CRA FILE LAWSUIT AGAINST FDA
The three major cigar and tobacco industry associations filed suit Thursday against the United States Food and Drug Administration’s “Deeming Rule.” The Cigar Association of America, International Premium Cigar and Pipe Retailers Association, and the Cigar Rights of America are asking the District Court for the District of Columbia for a declaratory injunction “vacate, set aside and enjoin the enforcement of the final rule” because it is violates numerous federal statutes as well as the federal rulemaking process.